Prof. Dr. Helmut Friess
Academic Career and Research Areas
Professor Friess (b. 1962) has been the director of the Surgical Clinic and Policlinic at TUM’s Klinikum rechts der Isar since 2007. His research interests include the mechanisms of molecular development and the influence of growth factors on the aggressivity of pancreatic carcinoma. He has clarified many of the molecular signal pathways that contribute to the local infiltrative growth and metastasis of this extremely malignant tumor. In multiple surgical clinical trials he has examined various surgical techniques for resection of pancreatic tumors and leads multicenter studies on adjuvant therapies.
Professor Friess completed his medical degree at the University of Ulm and acquired his postdoctoral teaching qualification (habilitation) in 1998 at the University of Bern, Switzerland. Positions as a doctor and a scientist took him to the University of California at Irvine, USA (1992 – 1993), as an intern and later as a senior physician at the Inselspital of the University of Bern (1997 – 2001) and as a senior physician at the University Hospital in Heidelberg (2001 – 2007). Professor Friess is an honorary professor at the R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of the National Academy of Science of the Ukraine. Furthermore, he is a member of the General Assembly of the United European Gastroenterology Federation (UEGF) and Secretary of the European Digestive Surgery (EDS) and European Pancreatic Club (EPC).
- Dr. Hella Bühler-Preis, Universität Heidelberg (2005)
- Preisträger der Feldbausch Stiftung, Heidelberg (2003)
- Qualitätsförderpreis Gesundheit, Baden-Württemberg (2002)
- Chirurgischer Forschungspreis, Gesellschaft für Chirurgie, Schweiz (1996)
Shrikhande SV et al.: “Pancreatic resection for M1 pancreatic ductal adenocarcinoma”. Ann Surg Oncol. 2007; 14: 118-127.Abstract
Kleeff J et al.: “Surgery for recurrent pancreatic ductal adenocarcinoma”. Ann Surg. 2007; 245: 566-572.Abstract
Müller MW, et al.: “Middle segmental pancreatic resection: an option to treat benign pancreatic body lesions”. Ann Surg. 2006; 244: 909-918; discussion 918-920.Abstract
Seiler CA et al.: “Long-term results of a prospective randomized trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection”. Br J Surg. 2005; 92: 547-556.Abstract
Neoptolemos JP et al.: “The final results of the European Study Group for Pancreatic Cancer randomized controlled trial of adjuvant chemoradiotherapy and chemotherapy in patients with resectable pancreatic cancer”. N Engl J Med. 2004; 350: 1200-1210.Abstract